MRP, LLC dba Aquabiliti recalls AQUABILITI AQUASTAT 0.9% Sodium Chloride Injection syringe
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- The saline flush syringes may fail to meet USP criteria for stated sodium chloride content after 12 months.
- Products
-
- AQUABILITI AQUASTAT 0.9% Sodium Chloride Injection syringe
- Company
- MRP, LLC dba Aquabiliti
- Where it was sold
-
US Nationwide distribution in the states CO, FL, NC, NY, OH, PA, TN, TX, and VA.
Nationwide
- Units affected
- 3,080,000 syringes
- About this recall
- AQUABILITI AQUASTAT 0.9% Sodium Chloride Injection syringe, USP, 5mL in 12mL, REF 2T0805; and 3mL in 12mL, REF 2T0807, intermediate cartons containing 100 syringes, shipping cases containing 400 syringes, Rx, Sterile.